The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 237 of the 241 references it cites were found in a registry or an index.
Abstract
Objective: To develop clinical practice guidelines for the management of patients with primary aldosteronism. Participants: The Task Force included a chair, selected by the Clinical Guidelines Subcommittee of the Endocrine Society, six additional experts, a methodologist, and a medical writer. The guideline was cosponsored by American Heart Association, American Association of Endocrine Surgeons, European Society of Endocrinology, European Society of Hypertension, International Association of Endocrine Surgeons, International Society of Endocrinology, International Society of Hypertension, Japan Endocrine Society, and The Japanese Society of Hypertension. The Task Force received no corporate funding or remuneration. Evidence: We searched for systematic reviews and primary studies to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation group criteria to describe both the quality of evidence and the strength of recommendations. We used “recommend” for strong recommendations and “suggest” for weak recommendations. Consensus Process: We achieved consensus by collecting the best available evidence and conducting one group meeting, several conference calls, and multiple e-mail communications. With the help of a medical writer, the Endocrine Society's Clinical Guidelines Subcommittee, Clinical Affairs Core Committee, and Council successfully reviewed the drafts prepared by the Task Force. We placed the version approved by the Clinical Guidelines Subcommittee and Clinical Affairs Core Committee on the Endocrine Society's website for comments by members. At each stage of review, the Task Force received written comments and incorporated necessary changes. Conclusions: For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions and recommend that a commonly used confirmatory test should confirm/exclude the condition. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend that an experienced radiologist should establish/exclude unilateral primary aldosteronism using bilateral adrenal venous sampling, and if confirmed, this should optimally be treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia or those unsuitable for surgery should be treated primarily with a mineralocorticoid receptor antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Algorithm for the detection, confirmation, subtype testing, and treatment of PA. a We recommend unilateral laparoscopic adrenalectomy for patients with documented unilateral PA (ie, APA or UAH) (1 ⎪ QQQE ). If a patient is unable or unwilling to undergo surgery, we recommend medical treatment including a MR antagonist (1 ⎪ QQQE ). If an ARR-positive patient is unwilling or unable to undergo further investigations, we similarly recommend medical treatment including an MR antagonist (1 ⎪ QQEE ). b Instead of proceeding directly to subtype classification, we recommend that patients with a positive ARR undergo one or more confirmatory tests to definitively confirm or exclude the diagnosis (1 ⎪ QQEE ). However, in the setting of spontaneous hypokalemia, undetectable renin, and PAC > 20 ng/dL (550 pmol/L), we suggest that there may be no need for further confirmatory testing (2 ⎪ QEEE ). c We recommend that when surgical treatment is feasible and desired by the patient, an experienced radiologist should use AVS to make the distinction between unilateral and bilateral adrenal disease (1 ⎪ QQQE ). Younger patients ( < age 35) with spontaneous hypokalemia, marked aldosterone excess, and unilateral adrenal lesions with radiological features consistent with a cortical adenoma on adrenal CT scan may not need AVS before proceeding to unilateral adrenalectomy (2 ⎪ QEEE ). [Adapted from J. W. Funder et al: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab . 2008;93:3266-3281 (3), with permission. © Endocrine Society.]](https://figures.cochat.ai/paper-figures/aaade82f5c4b425bbdee69e74321806d/the-management-of-primary-aldosteronism-case-detection-diagnosis-and-treatment-figure-1.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common types of secondary hypertension in adults are renal parenchymal disease, renovascular hypertension, primary aldosteronism, chronic sleep apnea, and substance/drug-induced.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A specific cause of secondary hypertension can be identified in 5%-10% of hypertensive patients (Table 11).”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early diagnosis of secondary hypertension and the institution of appropriate targeted treatment have the potential to cure hypertension in some patients or improve BP control/reduce the number of prescribed antihypertensive medications in others.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [116]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypokalemia, which reduces aldosterone secretion, should be corrected with oral K+ supplements before testing.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [289]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with unilateral disease (50%; aldosterone-producing adenoma or, much less frequently, unilateral hyperplasia) respond to unilateral laparoscopic adrenalectomy with complete cure (≈50%) or improvement (≈50%) in BP control.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [289]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation group, an international group with expertise in the development and implementation of evidence-based guidelines (2).”
MethodNational High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) · PEDIATRICS · doi:10.1542/peds.114.2.s2.555 · Cited by 6,938
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554 · cited 3×
“The recommendations and suggestions made by the Task Force were subject to extensive consultation before being published in the Journal of Clinical Endocrinology and Metabolism in 2008 (3).”
MethodSelf-citationEvidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547 · cited 2×
“Several outcome studies also have provided evidence that PA patients are particularly at risk of cardiovascular/ renal complications, including arrhythmias, myocardial infarction, strokes, chronic kidney disease, and death, compared with age-, sex-, and BP-matched essential hypertensives (30, 33, 156).”
BackgroundResultA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467 · cited 2×
“However, some groups have suggested that when clinicians administer a bolus injection of cosyntropin and sample the adrenal veins simultaneously, cosyntropin does not improve the diagnostic accuracy of AVS, and, in fact, cosyntropin may increase secretion from the nonadenomatous gland to a greater degree than from the…”
BackgroundSelf-citation
Research works printed but not linked: 3
- 15. Tucker RM, Labarthe DR. Frequency of surgical treatment for hypertensioninadultsattheMayoClinicfrom1973through1975. Mayo Clin Proc . 1977;52:549-545.
- 133. FardellaCE,PintoM,MossoL,Gómez-SánchezC,JalilJ,Montero J. Genetic study of patients with dexamethasone-suppressible aldosteronismwithoutthechimericCYP11B1/CYP11B2gene. J Clin Endocrinol Metab . 2001;86:4805-4807.
- 169. Jacobsen NE, Campbell JB, Hobart MG. Laparoscopic versus openadrenalectomyforsurgicaladrenaldisease. CanJUrol . 2003; 10:1995-1999.
Cited by
Items 901–1,000 of 1,002
Zekarias, K., & Tessier, K. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.11.085 · Cited by 13
Persistent cardiac organ damage in surgically and medically treated primary aldosteronism
Aune, A., Gerdts, E., Kokorina, M., Kringeland, E. A., Midtbø, H. B., Løvås, K., & Grytaas, M. A. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003135 · Cited by 13
“Primary aldosteronism was confirmed by recumbent saline infusion testing (SIT), and subtype differentiation was done by cosyntropin-stimulated adrenal vein sampling in all patients, as previously described, and in accordance with current guidelines [3,10].”
BackgroundMethodAsla, Q., Sardà, H., Lerma, E., Hanzu, F. A., Rodrigo‐Calvo, M. T., Urgell, E., Pérez, J. I., Webb, S. M., & Aulinas, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.846865 · Cited by 14
Ozeki, Y., Kinoshita, M., Miyamoto, S., Yoshida, Y., Okamoto, M., Gotoh, K., Masaki, T., Kambara, K., & Shibata, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.859347 · Cited by 13
Self-citationDisorders of the adrenal cortex: Genetic and molecular aspects
Pitsava, G., Maria, A. G., & Faucz, F. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931389 · Cited by 15
Case report: Percutaneous adrenal arterial embolization cures resistant hypertension
Zhou, Y., Wang, D., Liu, Q., Hou, J., & Wang, P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1013426 · Cited by 13
“Unilateral laparoscopic adrenalectomy is recommended over medical treatment for patients with unilateral primary aldosteronism according to the current clinical practice guideline (3).”
BackgroundAlnazer, R. M., Veldhuizen, G. P., de Leeuw, P. W., & Kroon, A. A. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003377 · Cited by 13
“A lthough current guidelines recommend measuring the aldosterone-to-renin ratio (ARR) as a screening test for primary aldosteronism [1], sensitivity and specificity of the ARR have a wide and variable range.”
BackgroundStrategies for subtyping primary aldosteronism
Yang, Y.-H., Chang, Y., Lee, B., Lu, C., Wang, W., Hu, Y., Liu, H.-W., Lin, Y., Chang, C., Wu, W.-C., et al. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.05.004 · Cited by 13
Tseng, C., Chan, C., Lee, H.-Y., Pan, C., Peng, K., Wang, S., Huang, K., Tsai, Y., Wu, V., & Chueh, S. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.05.032 · Cited by 14
Ng, E., Gwini, S. M., Zheng, W., Fuller, P. J., & Yang, J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad451 · Cited by 13
Özcan, Ö., Hillebrand, J. J., den Elzen, W. P. J., & Heijboer, A. C. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae057 · Cited by 13
Ortiz‐Peláez, A., Pfeiffer, D. U., Tempia, S., Otieno, F., Aden, H. H., & Costagli, R. (2010) · BMC Veterinary Research · doi:10.1186/1746-6148-6-22 · Cited by 14
Lai, S., Petramala, L., Mastroluca, D., Petraglia, E., Gaeta, A. D., Indino, E. L., Panebianco, V., Ciccariello, M., Shahabadi, H., Galani, A., et al. (2016) · Medicine · doi:10.1097/md.0000000000004175 · Cited by 14
“In APA patients unilateral adrenalectomy was performed, and an adrenal adenoma was confirmed at histological examination.([17,18])”
MethodResultScreening for primary aldosteronism using the newly developed IDS-iSYS® automated assay system
O’Shea, P. M., Griffin, T. P., Browne, G. A., Gallagher, N., Brady, J. J., Dennedy, M. C., Bell, M., Wall, D., & Fitzgibbon, M. C. (2016) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2016.11.002 · Cited by 13
How to Escape from Primary Aldosteronism? News and Views on an Adrenal Disorder of Salt Retention
Willenberg, H. S. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-100767 · Cited by 14
“Patients with sustained blood pressure above 150/100 mm Hg, hypertension that is only controlled on 4 or more antihypertensive drugs, hypertension and spontaneous or diuretic-induced hypokalemia, hypertension and an incidentally discovered adrenal tumor, hypertension and sleep apnea, hypertension and a family history…”
BackgroundInfluentialCatena, C., Colussi, G., Martinis, F., Novello, M., & Sechi, L. A. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001476 · Cited by 13
“Primary aldosteronism was excluded after screening by an increased plasma aldosteroneto-active renin ratio in the presence of a plasma aldosterone concentration of 150 pg/ml or more, and confirmation of diagnosis by the lack of aldosterone suppression after a standard intravenous saline load [25] as reported previousl…”
MethodTargeted disruption of the Kcnj5 gene in the female mouse lowers aldosterone levels
Hardege, I., Long, L., Maskari, R. A., Figg, N., & O’Shaughnessy, K. M. (2017) · Clinical Science · doi:10.1042/cs20171285 · Cited by 13
“O ther stu d ies have a l so reporte d sex d ifferences in a d rena l phenotype, morpho l ogy an d gene expression in both inbre d strains an d genetica ll y mo d ifie d mice [2 1-23 ] .”
InfluentialPilz, S., Trummer, C., Verheyen, N., Theiler‐Schwetz, V., Pandis, M., Aberer, F., Grübler, M. R., Meinitzer, A., Bachmann, A., Voelkl, J. G. J., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0604-3249 · Cited by 13
“While this is still a matter of controversy, it should also be acknowledged that the recommended withdrawal time for MR blockers of 4 weeks before carrying out diagnostic evaluation for PA is based on rather limited evidence [1, 14].”
Influentialvan der Sande, N. G. C., Blankestijn, P. J., Visseren, F. L. J., Beeftink, M. M. A., Voskuil, M., Westerink, J., Bots, M. L., & Spiering, W. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001885 · Cited by 13
Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea
Wang, E. Y., Chomsky‐Higgins, K. H., Chen, Y., Nwaogu, I. Y., Seib, C. D., Shen, W. T., Duh, Q., & Suh, I. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.10.040 · Cited by 13
Aldosterone-Producing Adenomas
Hellman, P., Björklund, P., & Åkerström, T. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.007 · Cited by 14
Plasma renin levels are associated with cardiac function in primary adrenal insufficiency
Wolf, P. S., Beiglböck, H., Fellinger, P., Pfleger, L., Aschauer, S., Gessl, A., Marculescu, R., Trattnig, S., Kautzky‐Willer, A., Luger, A., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01974-1 · Cited by 14
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics
Leo, A. D., Mosconi, C., Zavatta, G., Tucci, L., Nanni, C., Selva, S., Balacchi, C., Ceccarelli, C., Santini, D., Pantaleo, M. A., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01198-5 · Cited by 13
Tan, S. Y. T., Ng, K. S., Tan, C., Chuah, M. B., Zhang, M., & Puar, T. H. K. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa033 · Cited by 13
“In our center, although all AVS procedures were deemed successful by current criteria [1,2], 4 of 61 (6.”
BackgroundMethodInfluentialDevelopments in Primary Aldosteronism Subtyping Using Steroid Profiling
Wannachalee, T., & Turcu, A. F. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1141-3526 · Cited by 14
“Unilateral PA accounts for 30–50 % of PA cases, and it is commonly caused by an aldosterone-producing adenoma (APA) [3].”
BackgroundMethodThiesmeyer, J. W., Ullmann, T. M., Greenberg, J. A., Williams, N., Limberg, J. N., Stefanova, D. I., Beninato, T. M., Finnerty, B. M., Vignaud, T., Leclerc, J., et al. (2020) · Surgery · doi:10.1016/j.surg.2020.04.017 · Cited by 13
A speckle tracking echocardiographic study on right ventricular function in primary aldosteronism
Chen, Y., Xu, T., Xu, J., Zhu, L.-M., Li, Y., & Wang, J. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002527 · Cited by 13
“All patients with aldosterone-producing adenoma underwent unilateral adrenalectomy after lateralization and had their diagnosis confirmed histopathologically [2,12,13].”
BackgroundChen, Y., Xu, T., Xu, J., Zhu, L.-M., Li, Y., & Wang, J. (2021) · Hypertension Research · doi:10.1038/s41440-021-00725-y · Cited by 13
Christou, F., Pivin, E., Denys, A. L., Abid, K., Zingg, T., Matter, M., Péchère-Bertschi, A., Maillard, M. P., Grouzmann, E., & Wuerzner, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.842968 · Cited by 13
Ito, A., Yamazaki, Y., Sasano, H., Matsubara, D., Fukushima, N., Tamba‐Sakaguchi, M., Tabata, K., Ashizawa, K., Takei, A., Koizumi, M., et al. (2017) · Pathology International · doi:10.1111/pin.12521 · Cited by 13
Leung, H., Woo, Y. C., Fong, C. H.-Y., Tan, K. C. B., Lau, E., Chan, K. W., & Leung, J. Y. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01114-6 · Cited by 14
St‐Jean, M., Bourdeau, I., Thérasse, É., & Lacroix, A. (2019) · Clinical Endocrinology · doi:10.1111/cen.14137 · Cited by 13
Predictors of successful outcome after adrenalectomy for unilateral primary aldosteronism
Saadi, A., Bedoui, M. A., Zaghbib, S., Boussaffa, H., Mokaddem, S., Nacef, I. B., Ayed, H., Derouiche, A., Khiari, K., Chakroun, M., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1205988 · Cited by 13
Mansour, N., Mittermeier, A., Walter, R., Schachtner, B. M., Rudolph, J., Erber, B. M., Schmidt, V. F., Heinrich, D. A., Brüdgam, D., Tschaidse, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1244342 · Cited by 14
Self-citationCaptopril challenge test: an underutilized test in the diagnosis of primary aldosteronism
Jahan, S., Yang, J., Hu, J., Li, Q., & Fuller, P. J. (2024) · Endocrine Connections · doi:10.1530/ec-23-0445 · Cited by 12
Tetti, M., Burrello, J., Goi, J., Parasiliti‐Caprino, M., Gioiello, G., Settanni, F., Monticone, S., Mulatero, P., & Mengozzi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158453 · Cited by 12
“The screening test was considered positive with an ARR ≥ 300 ng/L/ng mL − 1 h − 1 or ADRR ≥ 20 (ng/L)/(mIU/L) and aldosterone ≥ 100 ng/L [16,17].”
BackgroundMethodInfluentialClinical Review: The Approach to the Evaluation and Management of Bilateral Adrenal Masses
Sweeney, A. T., Hamidi, O., Dogra, P., Athimulam, S., Correa, R., Blake, M. A., McKenzie, T. J., Vaidya, A., Pacák, K., Hamrahian, A. H., et al. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.06.015 · Cited by 12
Active Choice Nudge to Increase Screening for Primary Aldosteronism in At-Risk Patients
Passman, J. E., Hwang, J., Tang, J., Fagen, M., Epps, M., Peifer, M. K., Howell, J. T., Cohen, J. B., Delgado, M. K., Wachtel, H., et al. (2024) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000001221 · Cited by 12
Targeting cholesterol-dependent adrenal steroidogenesis for management of primary aldosteronism
Wu, H., He, H., Tong, H. A. N., Tian, X. Y., & Zhu, Z. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.12.001 · Cited by 14
Szatko, A., Toboła, A., Falhammar, H., Zgliczyński, W., & Glinicki, P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1548344 · Cited by 12
Goldbaum, T. S., Ledesma, F. L., Guimaraes, A. G., Okubo, J., Kawahara, E. Z., Calsavara, V. F., Bortolotto, L. A., Chambo, J. L., Fragoso, M. C. B. V., Pereira, M. A. A., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf118 · Cited by 13
Namekawa, T., Utsumi, T., Tanaka, T., Kaga, M., Nagano, H., Kono, T., Kawamura, K., Kamiya, N., Imamoto, T., Suzuki, H., et al. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3822-5 · Cited by 14
Castro, M. A., Rojano, N. B., Argüeso, M. F., Corrales, E. P., Mendiguchía, L. J., & Cano, A. M. G. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.07.025 · Cited by 15
Kline, G. A., Leung, A. A. C., Sam, D., Chin, A., & So, B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa930 · Cited by 13
Zhang, L., Li, J., Li, N., Sun, N., Xie, L., Han, Q., Li, Y., Lu, X. Z., Sun, P., Li, Y., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002891 · Cited by 16
“With continuous improvement in detection techniques, previous studies have shown that the prevalence of primary aldosteronism in patients with hypertension is approximately 5–10% [30,31].”
MethodWang, X., Heinrich, D. A., Kunz, S. L., Heger, N., Sturm, L., Uhl, O., Beuschlein, F., Reincke, M., & Bidlingmaier, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-90901-4 · Cited by 13
Self-citationAsian Conference on Tumor Ablation Guidelines for Adrenal Tumor Ablation
Park, B. K., Fujimori, M., Shen, S.-H., & Pua, U. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1008 · Cited by 14
“ple is essential to localize a functioning mass prior to ablation [16,17].”
BackgroundReduction of Radiation Exposure in Adrenal Vein Sampling: Impact of the Rapid Cortisol Assay
Augustin, A. M., Torre, G. D., Fuß, C. T., Faßnacht, M., Bley, T. A., & Kickuth, R. (2021) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-1535-2566 · Cited by 12
“Adrenal vein sampling is a minimally invasive diagnostic procedure that represents an important step in subtype determination in patients with confirmed primary aldosteronism [1, 2].”
BackgroundAbnormal Laboratory Results: Approach to the diagnosis of secondary hypertension in adults
Siru, R., Conradie, J., Gillett, M. J., & Page, M. M. (2021) · Australian Prescriber · doi:10.18773/austprescr.2021.038 · Cited by 14
Immunomodulatory Potential of Diuretics
Bryniarski, P., Nazimek, K., & Marcinkiewicz, J. (2021) · Biology · doi:10.3390/biology10121315 · Cited by 14
New Trends in the Diagnosis and Management of Hypertension
Tinawi, M. (2022) · Cureus · doi:10.7759/cureus.22393 · Cited by 14
“Moreover, current guidelines that rely on ARR as the preferred screening for primary aldosteronism may need to be reevaluated.”
InfluentialOutcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism
Kim, J. H., Ahn, C. H., Kim, S. J., Lee, K. E., Kim, J. W., Yoon, H.-K., Lee, Y.-M., Sung, T.-Y., Kim, S. W., Shin, C. S., et al. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1391 · Cited by 12
“AVS is the gold standard for subtyping PA but is invasive, technically challenging, and has limited availability [1,4].”
BackgroundMethodInfluentialWrenn, S. M., Vaidya, A., & Lubitz, C. C. (2020) · Gland Surgery · doi:10.21037/gs.2019.10.23 · Cited by 13
Petramala, L., Concistrè, A., Mezzadri, M., Sarlo, F., Circosta, F., Schina, M., Soldini, M., Iannucci, G., & Letizia, C. (2022) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2022.200138 · Cited by 13
Tannai, H., Makita, K., Koike, Y., Nakai, K., Tsurutani, Y., Okudela, K., Saito, J., Matsui, S., Kakuta, Y., & Nishikawa, T. (2022) · Clinical Radiology · doi:10.1016/j.crad.2022.05.010 · Cited by 12
Zibar, K., Dušek, T., Alduk, A., Knežević, N., Molnar, V., Kraljević, I., Polovina, T. Š., Balaško, A., Solak, M., Matas, N., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14794 · Cited by 13
“Receiver operating characteristic analysis was used to find the optimal A/C and AV/IVC cutoff values predicting the subtype of PA.”
MethodInfluentialQuencer, K. B., Singh, A., & Sharma, A. R. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.22.27692 · Cited by 15
Adrenal Venous Sampling Via an Antecubital Approach in Primary Aldosteronism: A Multicenter Study
Dong, H., Huang, J., Zhang, Y., Dong, Y., Liu, M., Yan, Z., Li, J., Chen, Y., Zou, Y., Wang, J., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad433 · Cited by 13
Yang, P., Tang, G., Sun, M., Yu, S., Cheng, Y., Wang, Y., Deng, W., Li, Y., & Guan, J. (2023) · European Radiology · doi:10.1007/s00330-023-10077-5 · Cited by 12
Evaluation of Adrenal Incidentaloma
Hu, J., Kassu, R. A., Titanji, B. N., & Kebebew, E. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.02.012 · Cited by 13
DeFronzo, R. A., Auchus, R. J., Bancos, I., Blonde, L., Busch, R. S., Buse, J. B., Findling, J. W., Fonseca, V. A., Frías, J. P., Hamidi, O., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081121 · Cited by 12
Buitenwerf, E., Dullaart, R. P. F., Kobold, A. C. M., Links, T. P., Sluiter, W. J., Connelly, M. A., & Kerstens, M. N. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.03.018 · Cited by 14
“0 confirmed that the blood sample was taken from the adrenal vein.(18) Lateralization of aldosterone secretion was considered to be compatible with the presence of an APA when the lateralization index (ie, plasma aldosteronedominant/plasma cortisoldominant : plasma aldosteronenondominant/plasma cortisolnondominant) wa…”
BackgroundGenovesi, S., Antolini, L., Orlando, A., Tassistro, E., Giussani, M., Nava, E., Turolo, L., Manolopoulou, J., Parati, G., & Morganti, A. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001571 · Cited by 12
Li, H., Zhang, X., Shen, S., Zhang, Y., Zhang, W., Feng, W., Li, P., & Zhu, D. (2018) · Steroids · doi:10.1016/j.steroids.2018.04.002 · Cited by 12
Breder, I. S. S., Garmes, H. M., Mazzola, T. N., Maciel‐Guerra, A. T., de Mello, M. P., & Guerra‐Júnior, G. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0521 · Cited by 13
Molecular genetics of Conn adenomas in the era of exome analysis
Zein, R. M. E., Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.07.006 · Cited by 12
“picture of patients with PA consists of HT, a high aldosterone to renin ratio, which has become one of the major diagnostic tools for PA alongside different confirmation tests and adrenal venous sampling for subtype diagnosis, and variable hypokalemia and metabolic alkalosis [5].”
Battistel, M., Ceolotto, G., Barbiero, G., Rossitto, G., & Rossi, G. P. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001827 · Cited by 12
“A drenal vein sampling (AVS) is key for deciding unilateral laparoscopic adrenalectomy in primary aldosteronism patients [1].”
BackgroundAdrenal incidentaloma: differential diagnosis and management strategies
Morelli, V., & Palmieri, S. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02868-7 · Cited by 14
Vivien, M., Deberles, E., Morello, R., Haddouche, A., Guénet, D., & Reznik, Y. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0857-1620 · Cited by 13
“The Endocrine Society guidelines have suggested that in the settings of spontaneous hypokalemia, plasma renin below levels of detection and baseline plasma aldosterone concentration (PAC) above 550 pmol/l (20 ng/dl), no further confirmatory testing should be performed [6].”
BackgroundLi, M., Ge, Q., Sheng, C., Zhang, J., Li, H., Niu, W., Tang, X., Xu, J., Gao, P., Wang, J., et al. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0208-9 · Cited by 13
Lin, Y.-F., Peng, K., Chang, C., Hu, Y., Wu, V., Chueh, S., & Wu, K. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00689 · Cited by 12
Li, S., Sun, H., Ma, L., Zhu, Y., Xie, W., Sun, J., Zhao, L., Qing, B., Ren, Y., Tian, H., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002271 · Cited by 12
“To date, bilateral adrenal vein sampling (AVS) is widely recommended to make a diagnosis of a primary aldosteronism subtype [2].”
BackgroundInfluentialClinical presentation and surgical outcomes in primary aldosteronism differ by race
Gershuni, V. M., Ermer, J. P., Kelz, R. R., Roses, R. E., Cohen, D. L., Trerotola, S. O., Fraker, D. L., & Wachtel, H. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25806 · Cited by 12
“surgically curable, while bilateral adrenal hyperplasia (BAH) is managed medically with mineralocorticoid antagonists.(11) Shorter duration of disease has been associated with improved operative outcomes in multiple studies of subjects with unilateral PA.”
BackgroundBasal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism
Saiki, A., Otsuki, M., Mukai, K., Hayashi, R., Shimomura, I., Kurihara, I., Ichijo, T., Takeda, Y., Katabami, T., Tsuiki, M., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa011 · Cited by 12
Primary aldosteronism in young adults with acute stroke: Prevalence and clinical characteristics
Tang, Z., Chen, H., He, W., Ma, L., Song, Y., Mei, M., Luo, T., Du, Z., Hu, J., Yang, S., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116774 · Cited by 12
Concistrè, A., Petramala, L., Bonvicini, M., Gigante, A., Collalti, G., Pellicano, C., Olmati, F., Iannucci, G., Soldini, M., Rosato, E., et al. (2020) · Hypertension Research · doi:10.1038/s41440-020-0475-4 · Cited by 12
Libianto, R., Menezes, S., Kaur, A., Gwini, S. M., Shen, J., Narayan, O. P., Fuller, P. J., Yang, J., & Young, M. J. (2020) · Clinical Endocrinology · doi:10.1111/cen.14373 · Cited by 12
“Day-night difference in systolic BP (mmHg) 13 (6, 21) 12 (4, 22) .”
Nakamaru, R., Yamamoto, K. I., Akasaka, H., Rakugi, H., Kurihara, I., Yoneda, T., Ichijo, T., Katabami, T., Tsuiki, M., Wada, N., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86290-3 · Cited by 13
Self-citationTeragawa, H., Oshita, C., Orita, Y., Hashimoto, K., Nakayama, H., Yamazaki, Y., & Sasano, H. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i5.1119 · Cited by 12
Clemente-Gutiérrez, U., Pérez-Soto, R. H., Hernández-Acevedo, J. D., Iñiguez‐Ariza, N. M., Casanueva-Pérez, E., Pantoja‐Millán, J. P., Sierra‐Salazar, M., Herrera, M. F., & Velázquez‐Fernández, D. (2021) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02245-2 · Cited by 13
Approach to the Patient with an Incidental Adrenal Mass
He, X., Peter, P. R., & Auchus, R. J. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.009 · Cited by 15
Sung, T., Tennakoon, L., Alobuia, W. M., Seib, C. D., Cisco, R. M., Lin, D. T., & Kebebew, E. (2021) · Surgery · doi:10.1016/j.surg.2021.10.065 · Cited by 15
Validation of three novel clinical prediction tools for primary aldosteronism subtyping
Kocjan, T., Vidmar, G., Popovič, P., & Stankovič, M. (2022) · Endocrine Connections · doi:10.1530/ec-21-0532 · Cited by 12
Nakano, Y., Yoshimoto, T., Fukuda, T., Murakami, M., Bouchi, R., Minami, I., Hashimoto, K., Fujii, Y., Kihara, K., & Ogawa, Y. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0438-17 · Cited by 13
“7 mg/day) was assumed to be virtually equivalent to the previous study using low-dose SPL treatment (50 mg/day) (1, 18), which was found to be less effective than surgery for achieving the reversal of glomerular hyperfiltration (19).”
BackgroundMethodInfluentialPark, C. H., Hong, N., Han, K., Kang, S., Lee, C. R., Park, S., & Rhee, Y. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.2.236 · Cited by 12
Brioschi, V., Rutherford, L., Newell, K., Trotter, C., & Arthurs, G. (2020) · Veterinary and Comparative Orthopaedics and Traumatology · doi:10.1055/s-0039-3400313 · Cited by 13
de Paula, M. P., Moraes, A. B., de Souza, M. D. G. C., Cavalari, E. M. R., Campbell, R. C., Fernandes, G. D. S., Farias, M. L. F., de Mendonca, L. M. C., Madeira, M., Bouskela, E., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01360-z · Cited by 12
“Primary aldosteronism was investigated in those with concomitant hypertension or unexplained hypokalemia [15, 16].”
BackgroundOur evolving understanding of primary aldosteronism
Mehdi, A., Rao, P., & Thomas, G. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20166 · Cited by 12
“2,11 In the interest of convenience and automation, many laboratories have switched from the traditional plasma renin activity assay to a direct renin concentration assay.”
BackgroundMethodGkaliagkousi, Ε., Lazaridis, A. A., Anyfanti, P., Stavropoulos, K., Imprialos, K. P., Triantafyllou, Α., Mastrogiannis, Κ., Δούμα, Σ., & Doumas, M. N. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00639-9 · Cited by 12
“Diagnosis of PA Diagnosis of PA was established by measuring plasma aldosterone concentration (ng/dl, PAC) and plasma renin activity (ng/ml/h, PRA) through peripheral venous sampling [19].”
MethodInfluentialNakano, Y., Murakami, M., Hara, K., Fukuda, T., Horino, M., Takeuchi, A., Niitsu, Y., Shiba, K., Tsujimoto, K., Komiya, C., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14849 · Cited by 12
“ment based on mineralocorticoid receptor antagonists (MRA) for patients with bilateral PA.(1) A series of clinical studies have shown that renal hemodynamic”
BackgroundInfluentialKey to the Treatment of Primary Aldosteronism in Secondary Hypertension: Subtype Diagnosis
Zuo, R. M., Liu, S., Xu, L., & Pang, H. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01269-x · Cited by 12
“Only a small subset of young patients ( 35 years old) with spontaneous hypokalaemia, very low renin levels, high aldosterone levels, and clear unilateral adenomas may not require AVS [3, 34].”
BackgroundMethodInfluentialLi, N., Zhu, Q. J., Dang, Y., Zhou, Y., Cai, X., Heizhati, M., Zhang, D., Yao, X., Luo, Q., Hu, J., et al. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2503104 · Cited by 11
“…guidelines [15], such as polysomonography (PSG) test preparation and interpretation standards for obstructive sleep apnea syndrome (OSAS) [2,7,8], and the requirements of renin aldosterone determination on drugs and disease status during primary aldosteronism (PA) screening [2,8,16–18].”
BackgroundRuiz-Sánchez, J. G., Sánchez, Á. F., Cárdenas‐Salas, J., Fernández-Cagigao, Y., Bellassai, E. R. A., Rossello, G., Fernández‐Fernández, B., Moreno, B. J., Paniagua, A., Vázquez, C., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003822 · Cited by 11
“Patients assessed at the endocrine hypertension were referred from general endocrinology clinics where diseases other than hypertension were studied aldosteronism who were then classified according to whether they had primary aldosteronism or not.”
Chan, C., Yang, W., Lin, Y., Chang, C., Wu, V., & Chueh, S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf007 · Cited by 12
Lu, N., Chen, L., Yu, F., Xiao, Z., Xing, D., Zhong, J., Zeng, D., Wang, Y., Tang, S., He, Y., et al. (2025) · Surgery · doi:10.1016/j.surg.2025.109156 · Cited by 11
Discordance between adrenal vein sampling and imaging: the role of unilateral cortisol excess
Grundy, M., Leung, A. A. C., Hyrcza, M. D., Pasieka, J. L., Chan, D. S., Przybojewski, S. J., So, B., Orton, D. J., Harvey, A. M., & Kline, G. A. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf019 · Cited by 11
“In these situations of discord-ance, some investigators have insisted that AVS should be considered the reference standard 9,12,14,15 but there is little outcome data to support that surgery guided by AVS objectively leads to a better outcome, and indeed some studies have failed to show a…”
InfluentialYuan, L., Li, X., Sun, F., Tang, Y., Wang, W., Liu, W. Y., Sun, X., Luo, Y., Bu, X., Lu, Z., et al. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf029 · Cited by 11
Tang, R., Pu, J., & Huang, Z. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07312-0 · Cited by 12
“However, current guidelines allow certain patients to bypass AVS [6, 40–42], potentially introducing selection bias and influencing diagnostic outcomes.”
Risk of Hypertension and Chronic Kidney Disease Following Aldosterone Dysregulation
Townsend, R. R., Agiro, A., Luan, S., Brzozowski, K., Moyneur, É., Tétreault-Langlois, P., & Huang, J. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf183 · Cited by 13
Updates in the 2025 AHA/ACC Hypertension Guideline
Brown, C. A., Clark, D., & Jones, D. W. (2026) · Current Hypertension Reports · doi:10.1007/s11906-026-01372-9 · Cited by 13
Metadata
- Authors
- Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F.
- Affiliations
- Hudson Institute of Medical Research (AU)
- University of Virginia Health System (US)
- University of Padua (IT)
- Mayo Clinic (US)
- Klinikum of the Ludwig-Maximilians-University of Munich (M.R.), 80366 München, Bavaria, Germany
- Oita University (JP)
- The University of Queensland (AU)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-05-01
- Volume
- 101
- Issue
- 5
- Pages
- 1889-1916
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2290633895
- Semantic Scholar
- 36716f26ebd3b8e468f352d9132208c41e5688c0
- Cited by
- 2,925
- References
- 241
- Citations by year
- 2026: 236 · 2025: 397 · 2024: 315 · 2023: 329 · 2022: 329 · 2021: 315 · 2020: 293 · 2019: 238 · 2018: 200 · 2017: 188 · 2016: 72
- FWCI
- 233.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, adrenal computed tomography, adrenal vein sampling, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Adrenal Glands, Adrenalectomy, Aldosterone, Mineralocorticoid Receptor Antagonists, Humans, Hyperaldosteronism, Renin, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.